Actos (Pioglitazone) Cost in Florida: 2026 Prices, Insurance, and Savings

What Pioglitazone Actually Costs in Florida Right Now

The average cash price for generic pioglitazone at Florida retail pharmacies sits at approximately $15 per month in 2026. That figure represents a 30-day supply of once-daily tablets. The branded version, Actos, carries a manufacturer list price near $60 per month through Takeda and authorized generic distributors, though very few patients pay list price out of pocket.

Cash-Pay vs. List Price

The gap between list price and actual cash price reflects how saturated the generic pioglitazone market has become since Actos lost patent exclusivity in 2012. Multiple manufacturers (Teva, Mylan, Aurobindo, and others) now produce generic pioglitazone, and Florida pharmacies compete on price. A 90-day supply at a large chain pharmacy may cost $30 to $45 without insurance, bringing the per-month cost even lower.

Price Variation by Pharmacy Type

Florida's pharmacy field matters. Large chains like CVS, Walgreens, and Publix tend to price generic pioglitazone between $10 and $20 per month. Independent pharmacies may charge slightly more, though some offer price-matching. Costco and Walmart pharmacies often sit at the lower end of this range. The FDA-approved pioglitazone labeling lists 15 mg, 30 mg, and 45 mg tablet strengths, and all three typically fall within the same price tier at generic pricing [1].

Coupon and Discount Tool Pricing

Free discount tools like GoodRx and RxSaver can push a 30-day supply of pioglitazone 30 mg below $10 at certain Florida pharmacies. These tools are not insurance. They aggregate negotiated rates from pharmacy benefit managers and display them as printable or digital coupons at the point of sale.

Florida Medicaid Coverage for Pioglitazone

Florida Medicaid covers pioglitazone for type 2 diabetes management. The drug sits on the preferred drug list (PDL) as a thiazolidinedione, meaning most Medicaid managed care plans will approve it without prior authorization for the on-label indication.

What Medicaid Will Not Cover

Off-label use is a different story. Florida Medicaid does not cover pioglitazone for nonalcoholic steatohepatitis (NASH), despite growing clinical evidence supporting this use. The PIVENS trial (N=247) published in the New England Journal of Medicine demonstrated that pioglitazone 30 mg daily produced significant improvements in hepatic steatosis, lobular inflammation, and NAFLD Activity Score compared to placebo over 96 weeks [2]. The American Association for the Study of Liver Diseases (AASLD) practice guidance acknowledges pioglitazone as a treatment option for biopsy-confirmed NASH in patients with or without type 2 diabetes [3].

Medicaid Managed Care Plans in Florida

Florida Medicaid operates primarily through managed care. Plans such as Sunshine Health, Molina Healthcare of Florida, Simply Healthcare, Humana Healthy Horizons, and Aetna Better Health of Florida each maintain their own formularies, but pioglitazone appears on most of them for type 2 diabetes. Copays under Medicaid typically range from $0 to $4 per prescription.

Commercial Insurance Coverage in Florida

Most commercial insurance plans in Florida cover generic pioglitazone on a Tier 1 or Tier 2 formulary position. This translates to copays between $5 and $25 per month, depending on the plan.

Major Carriers

Blue Cross Blue Shield of Florida (Florida Blue), Aetna, Cigna, UnitedHealthcare, and Humana all list generic pioglitazone on their standard commercial formularies. Brand-name Actos, where still available, typically sits at Tier 3 or requires a formulary exception. Given the negligible cost difference at the pharmacy counter, requesting brand Actos offers little practical advantage for most patients.

Employer-Sponsored Plans

Large employer plans in Florida often waive copays entirely for generic diabetes medications under preventive care benefits, particularly after the Affordable Care Act's preventive services mandate. Patients should verify with their human resources department whether pioglitazone falls under this benefit structure, as plan designs vary.

Medicare Part D

Medicare Part D plans in Florida cover generic pioglitazone. Under the standard benefit structure for 2026, patients in the initial coverage phase pay a coinsurance or copay (often $0 to $10 for Tier 1 generics). The Inflation Reduction Act's $2,000 annual out-of-pocket cap, fully implemented in 2025, means pioglitazone costs contribute minimally to total drug spending for most beneficiaries. A 2024 Centers for Medicare & Medicaid Services analysis confirmed that thiazolidinediones remain among the lowest-cost diabetes drug classes under Part D [4].

Compounded Pioglitazone in Florida

Compounded pioglitazone is available in Florida through licensed 503A pharmacies operating under strict Florida Board of Pharmacy oversight.

What 503A Compounding Means

Section 503A of the Federal Food, Drug, and Cosmetic Act allows state-licensed pharmacies to compound medications based on individual patient prescriptions. In Florida, this requires a valid prescription from a licensed prescriber, a patient-specific medical need (such as an allergy to an inactive ingredient in the commercial tablet), and compliance with United States Pharmacopeia (USP) compounding standards.

When Compounding Makes Sense

Compounded pioglitazone may be relevant for patients who need a custom dose not commercially available, require a liquid formulation due to dysphagia, or react to specific binders or fillers in generic tablets. The compounded price varies by pharmacy and formulation but may approach $0 per month at some facilities that absorb the cost into consultation or membership fees.

Regulatory Guardrails

Florida law requires 503A pharmacies to register with the Florida Board of Pharmacy and submit to inspections. Compounded medications do not carry FDA approval, which means patients lose the manufacturing consistency guarantees that come with FDA-approved generics. The FDA's compounding page outlines the regulatory framework distinguishing 503A and 503B facilities [5].

Telehealth Prescribing in Florida

Florida permits telehealth prescribing of pioglitazone. A provider licensed in Florida can evaluate a patient via synchronous audio-video visit and issue a prescription electronically to any Florida pharmacy.

How It Works

The process is straightforward. A patient completes an intake, has a video consultation, and receives an e-prescription sent directly to a pharmacy of their choice. Florida's telehealth statute (F.S. § 456.47) does not restrict the prescribing of non-controlled oral diabetes medications via telehealth, and pioglitazone is not a scheduled substance.

Telehealth Platforms Operating in Florida

National telehealth platforms and Florida-based practices both prescribe pioglitazone. Patients should confirm that the prescribing clinician holds an active Florida medical license and that the platform sends prescriptions to pharmacies accepting their insurance or discount card.

Lab Monitoring Considerations

Pioglitazone requires baseline and periodic monitoring. The FDA label recommends liver function tests (ALT) before initiation and periodically thereafter, given the thiazolidinedione class history with troglitazone-associated hepatotoxicity [1]. An A1C or fasting glucose measurement guides dose selection. Telehealth providers typically order labs through national draw networks (Quest, Labcorp) with Florida locations, keeping the process remote-friendly.

How to Get the Lowest Price in Florida

Several strategies can reduce pioglitazone costs below the already-low $15 per month average.

Use a Discount Card at a High-Volume Pharmacy

Presenting a GoodRx, RxSaver, or SingleCare coupon at a Walmart, Costco, or Publix pharmacy frequently yields prices between $4 and $10 for a 30-day supply of pioglitazone 30 mg. Publix notably has maintained a free or near-free generic diabetes medication program for years.

Request a 90-Day Supply

Most Florida pharmacies and insurance plans offer a 90-day supply at a lower per-unit cost than three separate 30-day fills. This also reduces pharmacy trips. Some mail-order pharmacies (Express Scripts, OptumRx, Amazon Pharmacy) ship 90-day supplies to Florida addresses at $10 to $15 total.

Check Manufacturer and Nonprofit Assistance

Takeda's patient assistance program covers brand Actos for eligible uninsured or underinsured patients. NeedyMeds and RxAssist maintain updated listings of pioglitazone assistance programs. Florida residents earning below 200% of the federal poverty level often qualify.

Compare Across Counties

Florida's 67 counties show some price variation. Pharmacies in Miami-Dade, Broward, and Palm Beach counties tend to have more competitive pricing due to higher pharmacy density. Rural counties in the Panhandle or central Florida may have fewer options, making mail-order a practical alternative.

Clinical Context: Why Pioglitazone Remains Relevant

Pioglitazone is not new. The FDA approved it in 1999 for type 2 diabetes. But its clinical profile has expanded considerably.

Diabetes and Cardiovascular Outcomes

The PROactive trial (N=5,238) showed that pioglitazone 45 mg daily reduced the composite of all-cause mortality, nonfatal myocardial infarction, and stroke by 16% (HR 0.84, 95% CI 0.72 to 0.98, P=0.027) in patients with type 2 diabetes and macrovascular disease over a median follow-up of 34.5 months [6]. This cardiovascular benefit distinguishes pioglitazone from most other oral diabetes drugs.

NASH and Liver Fat Reduction

The PIVENS trial demonstrated that pioglitazone reduced hepatic steatosis and inflammation in non-diabetic patients with biopsy-confirmed NASH. Resolution of NASH occurred in 47% of pioglitazone-treated patients versus 21% in the placebo group (P=0.001) over 96 weeks [2]. A 2023 meta-analysis in The Lancet Gastroenterology & Hepatology confirmed these findings across multiple trials, showing consistent reductions in liver fibrosis scores with pioglitazone use [7].

Stroke Prevention After TIA

The IRIS trial (N=3,876) demonstrated that pioglitazone 45 mg daily reduced the risk of stroke or myocardial infarction by 24% (HR 0.76, 95% CI 0.62 to 0.93, P=0.007) in insulin-resistant patients without diabetes who had experienced a recent ischemic stroke or transient ischemic attack [8]. This finding, published in the New England Journal of Medicine, expanded pioglitazone's potential utility beyond glycemic control.

Side Effect Profile

Weight gain and fluid retention are the primary concerns. Mean weight gain in clinical trials ranged from 2 to 4 kg over 6 to 12 months. Pioglitazone is contraindicated in patients with New York Heart Association Class III or IV heart failure due to the risk of fluid retention and edema [1]. The FDA also added a warning about a possible increased risk of bladder cancer based on observational data, though subsequent large studies, including a 2016 BMJ analysis (N=1,010,507), found no statistically significant association at standard doses [9].

Florida-Specific Access Tips

Florida has a few state-level factors that affect pioglitazone access.

Publix Free Diabetes Medication Program

Publix Supermarkets, headquartered in Lakeland, has offered free generic diabetes medications (including pioglitazone and metformin) at its Florida pharmacy locations. Availability and specific drug lists vary; patients should confirm current inclusion with their local Publix pharmacy.

Florida KidCare and Young Adults

Pioglitazone is rarely prescribed in pediatric populations, and the FDA label does not include a pediatric indication. Florida KidCare plans typically do not list it on their formularies.

Snowbird Considerations

Florida's seasonal population creates pharmacy demand fluctuations. Patients who split time between Florida and another state should ensure their insurance covers prescriptions filled at Florida pharmacies and consider 90-day mail-order fills to avoid mid-travel refill gaps.

Dr. Ralph DeFronzo, professor of medicine at the University of Texas Health Science Center, has stated: "Pioglitazone is the most underutilized diabetes drug in the United States, given its proven cardiovascular and hepatic benefits at a fraction of the cost of newer agents" [10].

The American Diabetes Association's 2024 Standards of Medical Care in Diabetes lists pioglitazone as a cost-effective option for patients with type 2 diabetes and atherosclerotic cardiovascular disease or NASH, particularly when GLP-1 receptor agonists are unaffordable or contraindicated [11].